Ocular Science® is an innovative biotech company based in Manhattan Beach, Calif., that provides cost-effective, efficacious products to physicians and their patients for surgical vision correction, myopia control and the management of glaucoma and dry eye disease. Founded in 2015 and guided by a medical advisory board of 30 world leaders in ophthalmology, we focus on the production of paradigm-shifting ophthalmic products that are easy to use, cost-effective and promote patient compliance. Our company is divided into two unique affiliates: OSRX™, Inc., a 503A compounding pharmacy that supplies 10 combinations of medications, as directed by prescribers, in four areas of ophthalmology; and Regenerative Science™, which innovates novel biologics for the management of dry eye disease.